Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of nonfunctioning pituitary adenomas

G Sassolas1, J Trouillas, C Treluyer

  • 1Centre de Médecine Nucléaire, Hôpital Neurologique, Lyon, France.

Acta Endocrinologica
|July 1, 1993
PubMed
Summary

Clinically nonfunctioning pituitary adenomas often cause visual impairment. Surgery is the primary treatment, though recurrence can occur, necessitating further therapies like radiation or medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A dynamical measure of the black hole mass in a quasar 11 billion years ago.

Nature·2024
Same author

Azimuthal Correlations within Exclusive Dijets with Large Momentum Transfer in Photon-Lead Collisions.

Physical review letters·2023
Same author

Measurements of the associated production of a W boson and a charm quark in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2022
Same author

Probing Charm Quark Dynamics via Multiparticle Correlations in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2022
Same author

First Search for Exclusive Diphoton Production at High Mass with Tagged Protons in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2022
Same author

Search for low-mass dilepton resonances in Higgs boson decays to four-lepton final states in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2022

Area of Science:

  • Neuroendocrinology
  • Oncology
  • Ophthalmology

Background:

  • Clinically nonfunctioning pituitary adenomas (NFAs) constitute a third of surgically treated pituitary tumors.
  • Symptoms primarily involve visual impairment, without hormonal hypersecretion.
  • While many NFAs express glycoprotein hormone subunits, 30% synthesize no detectable pituitary hormones.

Purpose of the Study:

  • To review the management of clinically nonfunctioning pituitary adenomas.
  • To outline treatment strategies and their efficacy in addressing visual defects and tumor remnants.

Main Methods:

  • Review of existing literature on NFA treatment modalities.
  • Analysis of surgical outcomes, radiation therapy, and medical treatments including dopamine agonists, somatostatin analogues, and GnRH analogues.

Main Results:

  • Surgery offers visual improvement in 80% of patients but leaves remnants in 30-50%.
  • Radiation therapy is used for incomplete resection, with a 20% recurrence rate.
  • Medical treatments show limited efficacy: dopamine agonists benefit 15%, somatostatin analogues offer minimal shrinkage, and GnRH analogues are ineffective for tumor size reduction.

Conclusions:

  • Surgery is the first-line treatment for NFAs, aiming for maximal tumor removal and visual improvement.
  • Adjuvant therapies like radiation and medical treatments are employed for residual or recurrent tumors, with varying degrees of success.
  • Further research into effective medical therapies for NFAs is warranted.

Related Experiment Videos